ArticleMolecular & cellular oncology2020

SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery.

Maria Bååth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.